Number of the records: 1  

In vivo expansion of activated naive CD8+ T cells and NK cells driven by complexes of IL-2 and anti-IL-2 monoclonal antibody as novel approach of cancer immunotherapy

  1. 1.
    SYSNO ASEP0334585
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleIn vivo expansion of activated naive CD8+ T cells and NK cells driven by complexes of IL-2 and anti-IL-2 monoclonal antibody as novel approach of cancer immunotherapy
    TitleIn vivo expanze aktivovaných CD8+ T buněk a NK buněk řízené komplexy IL-2 s anti-IL-2 monoklonální protilátkou jako nový přístup v imunoterapii nádorů
    Author(s) Tomala, Jakub (MBU-M) RID, ORCID
    Chmelová, Helena (MBU-M)
    Mrkvan, Tomáš (MBU-M)
    Říhová, Blanka (MBU-M) RID
    Kovář, Marek (MBU-M) RID, ORCID
    Source TitleJournal of Immunology. - : American Association of Immunologists - ISSN 0022-1767
    Roč. 183, č. 8 (2009), s. 4904-4912
    Number of pages9 s.
    Languageeng - English
    CountryUS - United States
    KeywordsNATURAL-KILLER-CELLS ; VASCULAR LEAK SYNDROME ; METASTATIC MELANOMA
    Subject RIVEC - Immunology
    R&D ProjectsIAA500200712 GA AV ČR - Academy of Sciences of the Czech Republic (AV ČR)
    KAN200200651 GA AV ČR - Academy of Sciences of the Czech Republic (AV ČR)
    GD310/08/H077 GA ČR - Czech Science Foundation (CSF)
    CEZAV0Z50200510 - MBU-M (2005-2011)
    UT WOS000270830300014
    DOI10.4049/jimmunol.0900284
    AnnotationThe work deals in vivo expansion of activated naive CD8+ T cells and NK cells driven by complexes of IL-2 and anti-IL-2 monoclonal antibody as novel approach of cancer immunotherapy
    WorkplaceInstitute of Microbiology
    ContactEliška Spurná, eliska.spurna@biomed.cas.cz, Tel.: 241 062 231
    Year of Publishing2010
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.